FAGR Fagron SA

Disclosure of received notification of Kabouter Management LLC

Disclosure of received notification of Kabouter Management LLC

Regulated information

Nazareth (Belgium)/Rotterdam (The Netherlands), 2 September 2022 – 6:00 PM CET

Disclosure of received notification of Kabouter Management LLC

Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received a notification from Kabouter Management LLC.

Notification of Kabouter Management LLC

  • On 1 September 2022, Fagron received a notification that the shareholding of Kabouter Management LLC had crossed the lowest disclosure threshold of 3% on 26 August 2022 as the result of the disposal of voting securities or voting rights.
  • The notification is made by a ‘parent undertaking or a controlling person’.
  • On 26 August 2022, Kabouter Management LLC held a total of 2,136,272 voting rights.
  • Based on the denominator of 72,992,654 (total number of voting rights), Kabouter Management LLC held 2.93% of the total number of voting rights on 26 August 2022.
  • Kabouter Management LLC is the company managing funds and accounts that owns voting securities in Fagron N.V. Kabouter Management LLC directly manages such voting securities (thus, without any subsidiaries or affiliates). Kabouter Management LLC is controlled by Mr. Peter Zaldivar and Mr. Marcel Houtzager.
  • Kabouter Management LLC is an investment fund manager which has voting discretion in relation to the voting securities in Fagron N.V. owned by its underlying funds and separate accounts. For such situation, article 9, §2 of the Royal Decree of 14 February 2008 provides that the management company (i.e. Kabouter Management LLC) needs to file the transparency declaration.
  • The notification of Kabouter Management LLC can be viewed via this .

Further information

Karen Berg

Global Investor Relations Manager

Tel. 99

 

About Fagron

Fagron is a leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics, and patients in 35 countries around the world.

Belgian company Fagron NV has its registered office in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. Fagron’s operational activities are managed by the Dutch company Fagron BV, which is headquartered in Rotterdam.

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

Please open the link below for the press release:



EN
02/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Fagron SA

Robert Jan Vos ... (+2)
  • Robert Jan Vos
  • Usama Tariq
Guy Sips ... (+8)
  • Guy Sips
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Kristof Samoy
  • Livio Luyten
  • Michiel Declercq
  • Thibault Leneeuw
  • Wim Lewi

Morning Notes : BAR BB, COFB BB, FAGR BB, GLPG NA, IBAB BB, DEME BB, N...

: BAR BB, COFB BB, FAGR BB, GLPG NA, IBAB BB, DEME BB, NXFIL NA, ENRGY BB

 PRESS RELEASE

Fagron versnelt globale expansie met twee strategische overnames en ve...

Fagron versnelt globale expansie met twee strategische overnames en verkrijgt belangrijke licentie in Noord Amerika Gereglementeerde informatie - voorkennisNazareth (België)/Rotterdam (Nederland), 19 december 2025 – 7:00 AM CET          Fagron versnelt globale expansie met twee strategische overnames en verkrijgt belangrijke licentie in Noord Amerika Fagron, de toonaangevende wereldwijde speler in farmaceutische bereidingen, is verheugd om twee strategische overnames aan te kondigen. Deze overnames helpen om onze globale aanwezigheid verder te versterken en capaciteiten te diversifiëren...

 PRESS RELEASE

Fagron accelerates global expansion with two strategic acquisitions an...

Fagron accelerates global expansion with two strategic acquisitions and a key North American licensing milestone Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 19 December 2025 – 7:00 AM CET Fagron accelerates global expansion with two strategic acquisitions and a key North American licensing milestone Fagron, the leading global player in pharmaceutical compounding, is pleased to announce two strategic acquisitions that further strengthen its global footprint and diversify its capabilities. These transactions include Amber Compounding Pharmacy, a...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Colruyt: Only 5 stores left to divest in France. EVS: Lower end of the range becomes the base case, on longer lead times. Fagron: Two EMEA acquisitions and California license for FSS. Kinepolis: “Wicked” achieves solid box office. OCI: Divesting Rotterdam ammonia terminal for €290m. Prosus: 1HFY26 results – on track

ResearchPool Subscriptions

Get the most out of your insights

Get in touch